I-Mab Announces IND Approval for Its Proprietary TJC4, A Potentially Differentiated CD47 Antibody, to Initiate Clinical Trials in China Jul 16, 2019 Life Science
Invitae to Acquire Jungla to Advance Genetic Variant Interpretation, Adds Supplemental RNA Analysis to Deliver Deeper, More Informative Results to Patients Jul 12, 2019 Life Science
MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China Jul 11, 2019 Life Science
SI Group Announces Focused Sale Of Industrial Resin Business to ASK Chemicals Jul 11, 2019 Life Science
Dr. Stuart Love Increases Role at Naturally Splendid; Natera(TM) Sports Bites Successfully Launched Jul 10, 2019 Life Science
